{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T09:01:59Z","timestamp":1766048519128},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,11,7]],"date-time":"2014-11-07T00:00:00Z","timestamp":1415318400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s12185-014-1694-8","type":"journal-article","created":{"date-parts":[[2014,11,14]],"date-time":"2014-11-14T17:59:22Z","timestamp":1415987962000},"page":"46-51","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Rituximab monotherapy as a first-line treatment for pulmonary mucosa-associated lymphoid tissue lymphoma"],"prefix":"10.1007","volume":"101","author":[{"given":"Ikue","family":"Okamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisao","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keita","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuto","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Isoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keichiro","family":"Mihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morio","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryusei","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,7]]},"reference":[{"issue":"8","key":"1694_CR1","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/1097-0142(19831015)52:8<1410::AID-CNCR2820520813>3.0.CO;2-3","volume":"52","author":"P Isaacson","year":"1983","unstructured":"Isaacson P, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer. 1983;52(8):1410\u20136.","journal-title":"Cancer"},{"key":"1694_CR2","volume-title":"Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). 4th ed. Lyon: International Agency for Research on Cancer (IARC); 2008.","edition":"4"},{"issue":"5","key":"1694_CR3","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2559.1995.tb00247.x","volume":"26","author":"AG Nicholson","year":"1995","unstructured":"Nicholson AG, Wotherspoon AC, Diss TC, Hansell DM, Du Bois R, Sheppard MN, et al. Reactive pulmonary lymphoid disorders. Histopathology. 1995;26(5):405\u201312.","journal-title":"Histopathology"},{"issue":"6","key":"1694_CR4","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/bjh.12703","volume":"164","author":"P Adam","year":"2014","unstructured":"Adam P, Czapiewski P, Colak S, Kosmidis P, Tousseyn T, Sagaert X, et al. Prevalence of Achromobacter xylosoxidans in pulmonary mucosa-associated lymphoid tissue lymphoma in different regions of Europe. Br J Haematol. 2014;164(6):804\u201310.","journal-title":"Br J Haematol"},{"issue":"9","key":"1694_CR5","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.ejca.2004.02.006","volume":"40","author":"S Ahmed","year":"2004","unstructured":"Ahmed S, Kussick SJ, Siddiqui AK, Bhuiya TA, Khan A, Sarewitz S, et al. Bronchial-associated lymphoid tissue lymphoma: a clinical study of a rare disease. Eur J Cancer. 2004;40(9):1320\u20136.","journal-title":"Eur J Cancer"},{"issue":"4","key":"1694_CR6","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.athoracsur.2005.04.014","volume":"80","author":"BB Graham","year":"2005","unstructured":"Graham BB, Mathisen DJ, Mark EJ, Takvorian RW. Primary pulmonary lymphoma. Ann Thorac Surg. 2005;80(4):1248\u201353.","journal-title":"Ann Thorac Surg"},{"key":"1694_CR7","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/1097-0142(196307)16:7<928::AID-CNCR2820160709>3.0.CO;2-H","volume":"16","author":"SL Saltzstein","year":"1963","unstructured":"Saltzstein SL. Pulmonary malignant lymphomas and pseudolymphomas: classification, therapy, and prognosis. Cancer. 1963;16:928\u201355.","journal-title":"Cancer"},{"issue":"12","key":"1694_CR8","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0046-8177(83)80258-5","volume":"14","author":"MN Koss","year":"1983","unstructured":"Koss MN, Hochholzer L, Nichols PW, Wehunt WD, Lazarus AA. Primary non-Hodgkin\u2019s lymphoma and pseudolymphoma of lung: a study of 161 patients. Hum Pathol. 1983;14(12):1024\u201338.","journal-title":"Hum Pathol"},{"issue":"1","key":"1694_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2559.1988.tb02000.x","volume":"13","author":"BJ Addis","year":"1988","unstructured":"Addis BJ, Hyjek E, Isaacson PG. Primary pulmonary lymphoma: a re-appraisal of its histogenesis and its relationship to pseudolymphoma and lymphoid interstitial pneumonia. Histopathology. 1988;13(1):1\u201317.","journal-title":"Histopathology"},{"issue":"8","key":"1694_CR10","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/00000478-200108000-00003","volume":"25","author":"PJ Kurtin","year":"2001","unstructured":"Kurtin PJ, Myers JL, Adlakha H, Strickler JG, Lohse C, Pankratz VS, et al. Pathologic and clinical features of primary pulmonary extranodal marginal zone B-cell lymphoma of MALT type. Am J Surg Pathol. 2001;25(8):997\u20131008.","journal-title":"Am J Surg Pathol"},{"issue":"Suppl 2","key":"1694_CR11","first-page":"S1","volume":"12","author":"DG Maloney","year":"2001","unstructured":"Maloney DG. Mechanism of action of rituximab. Anticancer Drugs. 2001;12(Suppl 2):S1\u20134.","journal-title":"Anticancer Drugs"},{"issue":"5","key":"1694_CR12","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/BF02982803","volume":"76","author":"AL Grillo-Lopez","year":"2002","unstructured":"Grillo-Lopez AL. Monoclonal antibody therapy for B-cell lymphoma. Int J Hematol. 2002;76(5):385\u201393.","journal-title":"Int J Hematol."},{"issue":"4","key":"1694_CR13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","volume":"346","author":"B Coiffier","year":"2002","unstructured":"Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002;346(4):235\u201342.","journal-title":"N Engl J Med"},{"issue":"4","key":"1694_CR14","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000074641","volume":"65","author":"M Raderer","year":"2003","unstructured":"Raderer M, Jager G, Brugger S, Puspok A, Fiebiger W, Drach J, et al. Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma. Oncology. 2003;65(4):306\u201310.","journal-title":"Oncology"},{"issue":"8","key":"1694_CR15","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1182\/blood-2002-11-3496","volume":"102","author":"A Conconi","year":"2003","unstructured":"Conconi A, Martinelli G, Thieblemont C, Ferreri AJ, Devizzi L, Peccatori F, et al. Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood. 2003;102(8):2741\u20135.","journal-title":"Blood"},{"issue":"9","key":"1694_CR16","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1016\/j.leukres.2009.03.026","volume":"33","author":"M Seker","year":"2009","unstructured":"Seker M, Bilici A, Ustaalioglu BO, Salman T, Sonmez B, Canpolat NA, et al. Extended rituximab schedules may result in increased efficacy in pulmonary malt lymphoma. Leuk Res. 2009;33(9):e154\u20136.","journal-title":"Leuk Res"},{"issue":"6","key":"1694_CR17","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3322\/canjclin.55.6.368","volume":"55","author":"JO Armitage","year":"2005","unstructured":"Armitage JO. Staging non-Hodgkin lymphoma. CA Cancer J Clin. 2005;55(6):368\u201376.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"1694_CR18","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","volume":"17","author":"BD Cheson","year":"1999","unstructured":"Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, et al. Report of an international workshop to standardize response criteria for non-Hodgkin\u2019s lymphomas. NCI Sponsored International Working Group. J Clin Oncol. 1999;17(4):1244.","journal-title":"J Clin Oncol"},{"issue":"5","key":"1694_CR19","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1200\/JCO.2011.40.6272","volume":"31","author":"E Zucca","year":"2013","unstructured":"Zucca E, Conconi A, Laszlo D, Lopez-Guillermo A, Bouabdallah R, Coiffier B, et al. Addition of rituximab to chlorambucil produces superior event-free survival in the treatment of patients with extranodal marginal-zone B-cell lymphoma: 5-year analysis of the IELSG-19 Randomized Study. J Clin Oncol. 2013;31(5):565\u201372.","journal-title":"J Clin Oncol"},{"issue":"7\u20138","key":"1694_CR20","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1081\/CNV-120005924","volume":"20","author":"S Ahmed","year":"2002","unstructured":"Ahmed S, Siddiqui AK, Rai KR. Low-grade B-cell bronchial associated lymphoid tissue (BALT) lymphoma. Cancer Invest. 2002;20(7\u20138):1059\u201368.","journal-title":"Cancer Invest"},{"issue":"1","key":"1694_CR21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1378\/chest.103.1.201","volume":"103","author":"JF Cordier","year":"1993","unstructured":"Cordier JF, Chailleux E, Lauque D, Reynaud-Gaubert M, Dietemann-Molard A, Dalphin JC, et al. Primary pulmonary lymphomas. A clinical study of 70 cases in nonimmunocompromised patients. Chest. 1993;103(1):201\u20138.","journal-title":"Chest"},{"issue":"4","key":"1694_CR22","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0003-4975(99)01535-0","volume":"69","author":"P Ferraro","year":"2000","unstructured":"Ferraro P, Trastek VF, Adlakha H, Deschamps C, Allen MS, Pairolero PC. Primary non-Hodgkin\u2019s lymphoma of the lung. Ann Thorac Surg. 2000;69(4):993\u20137.","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"1694_CR23","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1365-2559.1990.tb01157.x","volume":"16","author":"G Li","year":"1990","unstructured":"Li G, Hansmann ML, Zwingers T, Lennert K. Primary lymphomas of the lung: morphological, immunohistochemical and clinical features. Histopathology. 1990;16(6):519\u201331.","journal-title":"Histopathology"},{"issue":"5","key":"1694_CR24","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0046-8177(84)80074-X","volume":"15","author":"A Herbert","year":"1984","unstructured":"Herbert A, Wright DH, Isaacson PG, Smith JL. Primary malignant lymphoma of the lung: histopathologic and immunologic evaluation of nine cases. Hum Pathol. 1984;15(5):415\u201322.","journal-title":"Hum Pathol"},{"issue":"2","key":"1694_CR25","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1182\/blood.V96.2.410","volume":"96","author":"E Zucca","year":"2000","unstructured":"Zucca E, Bertoni F, Roggero E, Cavalli F. The gastric marginal zone B-cell lymphoma of MALT type. Blood. 2000;96(2):410\u20139.","journal-title":"Blood"},{"key":"1694_CR26","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1182\/asheducation-2001.1.241","volume":"2001","author":"F Cavalli","year":"2001","unstructured":"Cavalli F, Isaacson PG, Gascoyne RD, Zucca E. MALT lymphomas. Hematology Am Soc Hematol Educ Program. 2001;2001:241\u201358.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"7","key":"1694_CR27","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood-2002-04-1279","volume":"101","author":"E Zucca","year":"2003","unstructured":"Zucca E, Conconi A, Pedrinis E, Cortelazzo S, Motta T, Gospodarowicz MK, et al. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood. 2003;101(7):2489\u201395.","journal-title":"Blood"},{"issue":"4","key":"1694_CR28","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0360-3016(01)02714-6","volume":"52","author":"S Hitchcock","year":"2002","unstructured":"Hitchcock S, Ng AK, Fisher DC, Silver B, Bernardo MP, Dorfman DM, et al. Treatment outcome of mucosa-associated lymphoid tissue\/marginal zone non-Hodgkin\u2019s lymphoma. Int J Radiat Oncol Biol Phys. 2002;52(4):1058\u201366.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"1694_CR29","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1200\/JCO.1997.15.4.1624","volume":"15","author":"C Thieblemont","year":"1997","unstructured":"Thieblemont C, Bastion Y, Berger F, Rieux C, Salles G, Dumontet C, et al. Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients. J Clin Oncol. 1997;15(4):1624\u201330.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1694_CR30","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood.V95.3.802.003k19_802_806","volume":"95","author":"C Thieblemont","year":"2000","unstructured":"Thieblemont C, Berger F, Dumontet C, Moullet I, Bouafia F, Felman P, et al. Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood. 2000;95(3):802\u20136.","journal-title":"Blood"},{"issue":"4","key":"1694_CR31","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1200\/JCO.1999.17.4.1254","volume":"17","author":"PL Zinzani","year":"1999","unstructured":"Zinzani PL, Magagnoli M, Galieni P, Martelli M, Poletti V, Zaja F, et al. Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patients. J Clin Oncol. 1999;17(4):1254.","journal-title":"J Clin Oncol"},{"issue":"5\u20136","key":"1694_CR32","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3109\/10428199709050889","volume":"26","author":"G Pinotti","year":"1997","unstructured":"Pinotti G, Zucca E, Roggero E, Pascarella A, Bertoni F, Savio A, et al. Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma. Leuk Lymphoma. 1997;26(5\u20136):527\u201337.","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"1694_CR33","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1200\/JCO.1995.13.10.2524","volume":"13","author":"P Hammel","year":"1995","unstructured":"Hammel P, Haioun C, Chaumette MT, Gaulard P, Divine M, Reyes F, et al. Efficacy of single-agent chemotherapy in low-grade B-cell mucosa-associated lymphoid tissue lymphoma with prominent gastric expression. J Clin Oncol. 1995;13(10):2524\u20139.","journal-title":"J Clin Oncol"},{"issue":"5","key":"1694_CR34","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1200\/JCO.1998.16.5.1916","volume":"16","author":"NR Schechter","year":"1998","unstructured":"Schechter NR, Portlock CS, Yahalom J. Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone. J Clin Oncol. 1998;16(5):1916\u201321.","journal-title":"J Clin Oncol"},{"issue":"5","key":"1694_CR35","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0360-3016(01)01549-8","volume":"50","author":"RW Tsang","year":"2001","unstructured":"Tsang RW, Gospodarowicz MK, Pintilie M, Bezjak A, Wells W, Hodgson DC, et al. Stage I and II MALT lymphoma: results of treatment with radiotherapy. Int J Radiat Oncol Biol Phys. 2001;50(5):1258\u201364.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1694_CR36","unstructured":"NCCN clinical practice guidelines in oncology. Non-Hodgkin\u2019s lymphomas. http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/nhl.pdf . Accessed version 3, 2014"},{"issue":"4","key":"1694_CR37","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/hon.2039","volume":"31","author":"PL Zinzani","year":"2013","unstructured":"Zinzani PL, Pellegrini C, Gandolfi L, Casadei B, Derenzini E, Broccoli A, et al. Extranodal marginal zone B-cell lymphoma of the lung: experience with fludarabine and mitoxantrone-containing regimens. Hematol Oncol. 2013;31(4):183\u20138.","journal-title":"Hematol Oncol"},{"issue":"5","key":"1694_CR38","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2169\/internalmedicine.48.1438","volume":"48","author":"H Imai","year":"2009","unstructured":"Imai H, Sunaga N, Kaira K, Kawashima O, Yanagitani N, Sato K, et al. Clinicopathological features of patients with bronchial-associated lymphoid tissue lymphoma. Intern Med. 2009;48(5):301\u20136.","journal-title":"Intern Med"},{"issue":"6","key":"1694_CR39","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1183\/09031936.00039309","volume":"34","author":"R Borie","year":"2009","unstructured":"Borie R, Wislez M, Thabut G, Antoine M, Rabbat A, Couderc LJ, et al. Clinical characteristics and prognostic factors of pulmonary MALT lymphoma. Eur Respir J. 2009;34(6):1408\u201316.","journal-title":"Eur Respir J"},{"issue":"4","key":"1694_CR40","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3346\/jkms.2011.26.4.574","volume":"26","author":"A Bilici","year":"2011","unstructured":"Bilici A, Seker M, Ustaalioglu BB, Canpolat N, Salepci T, Gumus M. Pulmonary BALT lymphoma successfully treated with eight cycles weekly rituximab: report of first case and F-18 FDG PET\/CT images. J Korean Med Sci. 2011;26(4):574\u20136.","journal-title":"J Korean Med Sci"},{"issue":"9","key":"1694_CR41","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1023\/A:1008416911099","volume":"9","author":"NLG-LA Berinstein","year":"1998","unstructured":"Berinstein NLG-LA, White CA, et al. Association of serum rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin\u2019s lymphoma. Ann Oncol. 1998;9(9):995\u20131001.","journal-title":"Ann Oncol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-014-1694-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-014-1694-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-014-1694-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T20:53:53Z","timestamp":1598475233000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-014-1694-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,7]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["1694"],"URL":"https:\/\/doi.org\/10.1007\/s12185-014-1694-8","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,7]]}}}